Osteopontin as a Biomarker or Experimental Target for Outcomes After Ischemic Stroke: A Systematic Review of Human and Animal Studies.

Wu L, Fu Y

Open source

DOI
10.2174/0115672026531780261001042729
Published
2026 Oct 23
Container
Current neurovascular research
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0115672026531780261001042729,
  title = {Osteopontin as a Biomarker or Experimental Target for Outcomes After Ischemic Stroke: A Systematic Review of Human and Animal Studies.},
  author = {Wu L and Fu Y},
  year = {2026},
  journal = {Current neurovascular research},
  doi = {10.2174/0115672026531780261001042729},
  url = {https://doi.org/10.2174/0115672026531780261001042729}
}

RIS

TY  - JOUR
TI  - Osteopontin as a Biomarker or Experimental Target for Outcomes After Ischemic Stroke: A Systematic Review of Human and Animal Studies.
AU  - Wu L
AU  - Fu Y
PY  - 2026
JO  - Current neurovascular research
DO  - 10.2174/0115672026531780261001042729
UR  - https://doi.org/10.2174/0115672026531780261001042729
ER  - 

APA

L, W., & Y, F. (2026). Osteopontin as a Biomarker or Experimental Target for Outcomes After Ischemic Stroke: A Systematic Review of Human and Animal Studies.. Current neurovascular research. https://doi.org/10.2174/0115672026531780261001042729

Source records